Thursday, September 22, 2011

Ground Breaking Scientific Study Results Presented at North American Association of Laser Therapy

Dr. Lothar Lilge, a Professor in the Department of Medical Biophysics; University of Toronto will present at the North American Association of Laser Therapy (NAALT) at their 2011 Conference in Milwaukee, Wisconsin from September 22 to 24, 2011. The preclinical study by Theralase pertains to the mechanism of action of its 660 nm and 905 nm dual wavelength low level laser therapy (LLLT) and further explains how the patented Theralase technology activates the key inducible Nitric Oxide Synthase (iNOS) pathway. The research goes into detail to explain the importance of the iNOS pathway for accelerating the healing of tissue and why the Theralase dual wavelength technology is able to completely activate this key cellular pathway.

For further information, call 1-866-843-5273 or visit

No comments:

Post a Comment